From the biological perspective, this finding also supports the notion that NF-κB activation and related changes in gene expression may be the key factor determining the biological differences previously reported for TRAF3/CYLD mutant HPV+ HNSCC. This evidence concerns the gene TRAF3 and head and neck squamous cell carcinoma.